FR2392668A1 - Medicament a base de coproporphyrine - Google Patents

Medicament a base de coproporphyrine

Info

Publication number
FR2392668A1
FR2392668A1 FR7806295A FR7806295A FR2392668A1 FR 2392668 A1 FR2392668 A1 FR 2392668A1 FR 7806295 A FR7806295 A FR 7806295A FR 7806295 A FR7806295 A FR 7806295A FR 2392668 A1 FR2392668 A1 FR 2392668A1
Authority
FR
France
Prior art keywords
coproporphyrine
medicinal product
based medicinal
pharmaceutically acceptable
coproporphyrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7806295A
Other languages
English (en)
Other versions
FR2392668B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Nippon Oil Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Oil Corp filed Critical Nippon Oil Corp
Publication of FR2392668A1 publication Critical patent/FR2392668A1/fr
Application granted granted Critical
Publication of FR2392668B1 publication Critical patent/FR2392668B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention a pour objet un nouveau médicament. Ce médicament contient comme matière active de la coproporphyrine III ou un sel d'alcali minéral hydrosoluble de cette substance. Il peut être employé pour le traitement d'une grande variété de tumeurs malignes.
FR7806295A 1977-03-04 1978-03-06 Medicament a base de coproporphyrine Granted FR2392668A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2273077A JPS53109929A (en) 1977-03-04 1977-03-04 Medicin for malignant tumor

Publications (2)

Publication Number Publication Date
FR2392668A1 true FR2392668A1 (fr) 1978-12-29
FR2392668B1 FR2392668B1 (fr) 1980-05-16

Family

ID=12090857

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806295A Granted FR2392668A1 (fr) 1977-03-04 1978-03-06 Medicament a base de coproporphyrine

Country Status (4)

Country Link
JP (1) JPS53109929A (fr)
CH (1) CH636010A5 (fr)
DE (1) DE2809093A1 (fr)
FR (1) FR2392668A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
JPH0764728B2 (ja) * 1985-04-30 1995-07-12 日本石油化学株式会社 新規なテトラピロ−ル医薬用組成物
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
AU2002400A (en) * 1999-01-12 2000-08-01 Kyowa Hakko Kogyo Co. Ltd. Telomerase inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS527492A (en) * 1975-07-08 1977-01-20 Nippon Oil Co Ltd Preparation of coproporphyrin iii

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS527492A (en) * 1975-07-08 1977-01-20 Nippon Oil Co Ltd Preparation of coproporphyrin iii

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1949 *

Also Published As

Publication number Publication date
JPS53109929A (en) 1978-09-26
FR2392668B1 (fr) 1980-05-16
CH636010A5 (en) 1983-05-13
DE2809093A1 (de) 1978-09-28

Similar Documents

Publication Publication Date Title
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
SE8700498D0 (sv) Novel pharmaceologically active compounds
FR2678938B1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
FR2387220A1 (fr) Derives du benzimidazole et medicaments qui en contiennent
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
FR2392668A1 (fr) Medicament a base de coproporphyrine
SE7904485L (sv) Medicin innehallande para-aminobensoesyra-n-d-xylosid sasom en aktiv bestandsdel
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
ES479059A1 (es) Procedimiento para preparar derivados del naftaleno.
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires
GB2021409A (en) Pharmaceutical composition
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
JPS5241215A (en) Hydrophilic base material
SE8501518D0 (sv) Pharmazeutische preparate
SE7706061L (sv) 3,5,5-trimetylhexanoyl-ferrocen och forfarande for dess framstellning
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
GB1449043A (en) Treatment of asthma

Legal Events

Date Code Title Description
ST Notification of lapse